Jia Yao, Ji Seon Shim, Kelly Wong, James Zhu, Yunhe Liu, Sung Wook Kang, Kelli McCord, Bryan M Burt, Jong Min Choi, Claire Lee, Idania Carolina Lubo Julio, Luisa Maren Solis Soto, Sharia Hernandez, Karen Colbert Maresso, Yang Liu, Yibo Dai, Tian Chu, Wei Lu, Khaja Khan, Paul F Mansfield, Hee-Jin Jang, William H Hudson, Tao Yue, Bing Zhang, Changwei Li, Linghua Wang, Hao Zhu, Hyun-Sung Lee, Tao Wang
{"title":"Interpretable AI model reveals spatial codes of cell recruitment in tissues.","authors":"Jia Yao, Ji Seon Shim, Kelly Wong, James Zhu, Yunhe Liu, Sung Wook Kang, Kelli McCord, Bryan M Burt, Jong Min Choi, Claire Lee, Idania Carolina Lubo Julio, Luisa Maren Solis Soto, Sharia Hernandez, Karen Colbert Maresso, Yang Liu, Yibo Dai, Tian Chu, Wei Lu, Khaja Khan, Paul F Mansfield, Hee-Jin Jang, William H Hudson, Tao Yue, Bing Zhang, Changwei Li, Linghua Wang, Hao Zhu, Hyun-Sung Lee, Tao Wang","doi":"10.1038/s41551-026-01804-6","DOIUrl":null,"url":null,"abstract":"<p><p>Understanding which molecular signals recruit specific cells to precise tissue locations is fundamental to tissue biology, immunity and disease. Existing computational tools for spatially resolved transcriptomics (SRT) describe where cells reside but cannot explain why. Here we introduce SPACER, a fully interpretable multi-instance learning framework that decodes gene-level recruitment rules directly from SRT data. Applied to 37 SRT datasets spanning multiple human tumour types and mouse heart, SPACER achieved 4-21-fold improvement over existing methods in various tasks of recovering biologically meaningful recruitment signals. SPACER revealed (1) that tumour-expressed mucins are associated with physical barriers to T cell engagement, which predicts resistance to immune checkpoint inhibitors and patient prognosis, (2) that local antigen presentation is the dominant correlate of T cell engagement across cancer types and (3) that Cd4<sup>+</sup> T cells are the dominant functional effectors in severe immune checkpoint inhibitor-induced myocarditis. These findings establish SPACER as a discovery engine for cellular recruitment biology with direct translational applications.</p>","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":" ","pages":""},"PeriodicalIF":26.3000,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-026-01804-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Understanding which molecular signals recruit specific cells to precise tissue locations is fundamental to tissue biology, immunity and disease. Existing computational tools for spatially resolved transcriptomics (SRT) describe where cells reside but cannot explain why. Here we introduce SPACER, a fully interpretable multi-instance learning framework that decodes gene-level recruitment rules directly from SRT data. Applied to 37 SRT datasets spanning multiple human tumour types and mouse heart, SPACER achieved 4-21-fold improvement over existing methods in various tasks of recovering biologically meaningful recruitment signals. SPACER revealed (1) that tumour-expressed mucins are associated with physical barriers to T cell engagement, which predicts resistance to immune checkpoint inhibitors and patient prognosis, (2) that local antigen presentation is the dominant correlate of T cell engagement across cancer types and (3) that Cd4+ T cells are the dominant functional effectors in severe immune checkpoint inhibitor-induced myocarditis. These findings establish SPACER as a discovery engine for cellular recruitment biology with direct translational applications.
期刊介绍:
Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.